Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Tabelecleucel |
| Synonyms | |
| Therapy Description |
Tabelecleucel (ATA129) is a preparation of donor-derived EBV-specific cytotoxic T-cells, which may decrease growth of EBV-positive tumors (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Tabelecleucel | ATA129|ATA 129|EBV-CTL|Tab-cel | Tabelecleucel (ATA129) is a preparation of donor-derived EBV-specific cytotoxic T-cells, which may decrease growth of EBV-positive tumors (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|